BTAI

BioXcel Therapeutics, Inc. Common Stock

$1.19 +1.71%

Recent alerts on BTAI

All signals →

Insider trade Sale by Yocca Frank (Chief Scientific Officer)

Insider trade Sale by Rodriguez Javier (See Remarks)

Insider trade Sale by Steinhart Richard I (Chief Financial Officer)

Insider trade Sale by Mehta Vimal (CEO and President)

News 3 Supercharged Stocks Flashing Strong Momentum Signals

SEC filing BTAI Reports $206K Revenue, $12.7M Net Loss in Q1 2026

Scanner Unusual buy pressure (2.8x avg, 100% up-volume, +14.5% / +0.24 intraday, above VWAP)

SEC filing BTAI Enters Milestone and Retention Bonus Agreements for Key Employees, Offering $225K-$650K in Bonuses, Subject to Performance and Company Events

News BrianCell Therapeutics drops 10%, prices $30M offering at $5.59 per unit

SEC filing BTAI Holds Annual Meeting, Elects 3 Directors, Approves Accounting Firm, Potential Reverse Stock Split

Get push alerts for BTAI

Add it to your watchlist in the app and receive every signal the moment it fires.

Download for iOS

Download for iOS